| 1 |
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
(186 times)
|
Neoplasms
(85 times)
|
BCNU (31 times)
MISO (16 times)
MeCCNU (8 times)
|
1971 Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
|
| 2 |
1-cyclohexyl-3-nitroso-1-urea
(6 times)
|
Neoplasms
(4 times)
|
RT (2 times)
FSRT (1 time)
IGRT (1 time)
|
1976 Combination chemotherapy of advanced lung cancer: a randomized trial.
|
| 3 |
chemotherapy consisting of lomustine
(6 times)
|
Neoplasms
(3 times)
|
BSI (2 times)
FLIC (2 times)
CT (1 time)
|
1982 Salvage chemotherapy for non-Hodgkin's lymphoma.
|
| 4 |
chemotherapy with procarbazine, lomustine
(6 times)
|
Neoplasms
(3 times)
|
RTOG (2 times)
AOs (1 time)
CCTs (1 time)
|
2004 Diagnosis and management of oligodendroglioma.
|
| 5 |
combination of procarbazine, lomustine
(6 times)
|
Neoplasms
(3 times)
|
ECOG (1 time)
OG (1 time)
OS (1 time)
|
1988 Successful chemotherapy for recurrent malignant oligodendroglioma.
|
| 6 |
cyclophosphamide, and lomustine
(6 times)
|
Neoplasms
(4 times)
|
CALGB (1 time)
CP (1 time)
LMS (1 time)
|
1977 Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
|
| 7 |
cyclonexyl-chloroethyl-nitrosourea
(4 times)
|
Neurology
(2 times)
|
DLT (1 time)
JPA (1 time)
PFS (1 time)
|
1994 Aplastic anemia induced by cyclohexylchloroethylnitrousurea.
|
| 8 |
2-cyclohexyl-1-(2-chloroethyl)-1-nitrosourea
(2 times)
|
Pharmacology
(2 times)
|
BCNU (1 time)
NI-CENUs (1 time)
|
1989 Pathways and kinetics of aqueous decomposition and carbamoylating activity of new anticancer nitroimidazole-linked 2-chloroethylnitrosoureas.
|
| 9 |
combination of streptozotocin, lomustine
(2 times)
|
Neoplasms
(1 time)
|
ABVD (1 time)
MOPP (1 time)
|
1988 Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
|
| 10 |
1,3-cis(2-chloroethyl)-1-nitrosourea
(1 time)
|
Neoplasms
(1 time)
|
5-FU (1 time)
MeCCNU (1 time)
|
1977 Gastric cancer: current status of treatment.
|
| 11 |
beta-CNU greater than HEX-CNU greater than lomustine
(1 time)
|
Antineoplastic Agents
(1 time)
|
ER (1 time)
|
1987 Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
|
| 12 |
calcium leucovorin rescue, and lomustine
(1 time)
|
Antineoplastic Agents
(1 time)
|
CT (1 time)
SCCB (1 time)
SIADH (1 time)
|
1982 Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
|
| 13 |
carmustine (BiCNU IV) was substituted by oral lomustine
(1 time)
|
Transplantation
(1 time)
|
---
|
2012 Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol.
|
| 14 |
Chemotherapy consisted of six drugs: before lomustine
(1 time)
|
Neoplasms
(1 time)
|
AG (1 time)
FUHU (1 time)
GM (1 time)
|
1992 Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.
|
| 15 |
chemotherapy in standard and intensified formulations of procarbazine, lomustine
(1 time)
|
Neurology
(1 time)
|
---
|
1996 Low-grade oligodendroglioma responds to chemotherapy.
|
| 16 |
chemotherapy included methylprednisolone, vincristine, lomustine
(1 time)
|
Neoplasms
(1 time)
|
HD-MTX (1 time)
|
1988 Eight drugs in one day chemotherapy in children with brain tumors: a critical toxicity appraisal.
|
| 17 |
chemotherapy regimen initially developed for AIDS-related non-Hodgkin's lymphoma includes lomustine
(1 time)
|
Drug Therapy
(1 time)
|
---
|
2000 Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.
|
| 18 |
chemotherapy with prednisolone, cytosine arabinoside, lomustine
(1 time)
|
Neoplasms
(1 time)
|
NHL (1 time)
|
1993 Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
|
| 19 |
childhood brain tumours in vitro: evidence of differential sensitivity to lomustine
(1 time)
|
Neoplasms
(1 time)
|
MTT (1 time)
PCB (1 time)
PNET (1 time)
|
2000 Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.
|
| 20 |
cisplatin, one VP-16, and four methotrexate, procarbazine, and lomustine
(1 time)
|
Neoplasms
(1 time)
|
SCLC (1 time)
TNM (1 time)
|
1988 Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung.
|
| 21 |
co-deletion benefit particularly from the addition of procarbazine/lomustine
(1 time)
|
Neoplasms
(1 time)
|
AO (1 time)
RT (1 time)
|
2013 Anaplastic oligodendroglioma: a new treatment paradigm and current controversies.
|
| 22 |
combination chemotherapy with procarbazine, lomustine
(1 time)
|
Neoplasms
(1 time)
|
CI (1 time)
OA (1 time)
OD (1 time)
|
2003 Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
|
| 23 |
combination of DNA alkylating agents, procarbazine and lomustine
(1 time)
|
Biological Science Disciplines
(1 time)
|
ALKBH (1 time)
alpha-KG (1 time)
D-2HG (1 time)
|
2015 Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents.
|
| 24 |
combination of mitomycin C, lomustine
(1 time)
|
Neoplasms
(1 time)
|
MCM (1 time)
PSs (1 time)
|
1986 Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.
|
| 25 |
combination with irinotecan or lomustine
(1 time)
|
Chemistry
(1 time)
|
BEV (1 time)
MRI (1 time)
OS (1 time)
|
2017 Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.
|
| 26 |
compared with vincristine, lomustine
(1 time)
|
Neoplasms
(1 time)
|
MB (1 time)
PFS (1 time)
|
1999 Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
|
| 27 |
consisted of postoperative local-field radiotherapy and adjuvant chemotherapy, either lomustine
(1 time)
|
Neoplasms
(1 time)
|
AA (1 time)
GBM (1 time)
OS (1 time)
|
1995 Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
|
| 28 |
consisting of procarbazine, vincristine, and lomustine
(1 time)
|
Neoplasms
(1 time)
|
MST (1 time)
MTP (1 time)
RT (1 time)
|
1991 A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.
|
| 29 |
conventional chemotherapeutic agent lomustine
(1 time)
|
Antineoplastic Agents
(1 time)
|
---
|
1983 Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
|
| 30 |
correlated with response of oligodendroglial tumors to procarbazine, lomustine
(1 time)
|
Neurology
(1 time)
|
MTP (1 time)
|
1998 Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.
|
| 31 |
craniospinal RT and randomized to receive either vincristine, lomustine
(1 time)
|
Neoplasms
(1 time)
|
PFS (1 time)
PNETs (1 time)
RT (1 time)
|
1995 Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.
|
| 32 |
critical normal tissues is the nitrosourea lomustine
(1 time)
|
Antineoplastic Agents
(1 time)
|
---
|
1985 Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
|
| 33 |
curcumin as well as lomustine
(1 time)
|
Cells
(1 time)
|
CSEN (1 time)
DDR (1 time)
GBM (1 time)
|
2022 Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
|
| 34 |
cutaneous epitheliotropic lymphoma to lomustine
(1 time)
|
Internal Medicine
(1 time)
|
---
|
2006 Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004).
|
| 35 |
CYC + VCR + ADM + lomustine
(1 time)
|
Antineoplastic Agents
(1 time)
|
ADM (1 time)
CYC (1 time)
VCR (1 time)
|
1988 Survival analysis of patients with small cell lung cancer.
|
| 36 |
cycles at 6-weekly intervals of oral lomustine
(1 time)
|
Hematology
(1 time)
|
CR (1 time)
LEMP (1 time)
NHL (1 time)
|
1993 Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
|
| 37 |
cycles of Lomustine
(1 time)
|
Neoplasms
(1 time)
|
CSF (1 time)
GBM (1 time)
|
2008 Cryptococcal meningitis in patients with glioma: a report of two cases.
|
| 38 |
cycles of procarbazine, Lomustine
(1 time)
|
Neoplasms
(1 time)
|
AO (1 time)
AOA (1 time)
APBPCR (1 time)
|
2008 A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
|
| 39 |
cyclophosphamide, vincristine, daunorubicin, etoposide, teniposide, lomustine
(1 time)
|
Neoplasms
(1 time)
|
---
|
1984 Differentiated treatment of myeloma. A non-randomised phase two study.
|
| 40 |
cyclophosphamide, vincristine, procarbazine, and prednisone or lomustine
(1 time)
|
Neoplasms
(1 time)
|
DFS (1 time)
IEP (1 time)
OS (1 time)
|
2005 Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
|
| 41 |
cytotoxic drugs, lomustine
(1 time)
|
Neoplasms
(1 time)
|
MTT (1 time)
PCB (1 time)
PNET (1 time)
|
2000 Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.
|
| 42 |
cytotoxicity of Lomustine
(1 time)
|
Medicine
(1 time)
|
NO (1 time)
|
2004 [Suppression of nitric oxide on cytotoxicity of Lomustine in glioma cell line BT- 325].
|
| 43 |
cytotoxicity of melphalan, lomustine
(1 time)
|
Cell Biology
(1 time)
|
4HA (1 time)
AzA (1 time)
|
1996 Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines.
|
A Search Service for Abbreviation / Long Form